Subscribe
ericsphotography-istockphoto-com-us-gavel-2-1
ericsphotography / iStockphoto.com
25 May 2018Americas

FTC antitrust charges against Impax dismissed

A judge has found it unlikely that Impax Laboratories would launch a generic drug before a final court decision in related patent litigation and has dismissed a case against the company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Lannett gains generic product portfolio from Endo subsidiary
9 May 2018   Generic drug manufacturer Lannett has acquired the product portfolio of an Endo International subsidiary.
Americas
Amneal and Impax merge to become ‘fifth largest’ generics company
19 October 2017   Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Lannett gains generic product portfolio from Endo subsidiary
9 May 2018   Generic drug manufacturer Lannett has acquired the product portfolio of an Endo International subsidiary.
Americas
Amneal and Impax merge to become ‘fifth largest’ generics company
19 October 2017   Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US.

More on this story

Americas
Lannett gains generic product portfolio from Endo subsidiary
9 May 2018   Generic drug manufacturer Lannett has acquired the product portfolio of an Endo International subsidiary.
Americas
Amneal and Impax merge to become ‘fifth largest’ generics company
19 October 2017   Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent